3
Oct
2021
Pharma Case Study: Merck’s $11.5B acquisition of Acceleron
Merck will acquire Acceleron Pharma, Inc. XLRN for $180 per share in cash for an approximate total equity value of... Read More
+91-98 455 710 46 | info@nckpharma.com
Sign In
|Sign Up
Please sign in first
Not a member?
Please simply create an account before buying/booking any courses.
Create an account for free!
- Home
- About Us
- NCK services
- Course List
- Admission
- Course Quick Glance
- Features of Online Courses
- Course Catalogue
- Course Application form
- Admission Notification & Special Offers
- Frequently asked question related to KPE courses
- Prospect Identification Process
- Final Examination Registration
- How to change / reset password?
- Course Upgrade
- Verify Course Certificate
- Request for Course Completion Certificate
- Knowledge Base
- Contact
Recently Published Articles
3
Oct
2021
Sanofi Bangladesh Limited’s majority stake is acquired by Beximco Pharma, Bangladesh
Beximco Pharmaceuticals Limited, one of leading pharmaceutical company based at Bangladesh, have completed its acquisition of the majority stake (54.6%)... Read More
7
Sep
2021
What are the difference between Wholesaler and Specialty Pharmacy?
There are clear cut difference between the two terms. The wholesalers are the first purchaser of the drug, directly from... Read More
6
Sep
2021
What is Scale-Up and Post Approval Changes (SUPAC) report?
The scale-up process and the changes made after approval in the composition, manufacturing process, manufacturing equipment, and change of site... Read More
6
Sep
2021
What is the meaning of scale up in pharmaceutical industry?
A Scale-up is an important concept in pharmaceutical and biopharmaceutical manufacturing industry. It is defined as to take a biopharmaceutical... Read More
6
Sep
2021
RIL arm acquires stake in Strand Life Sciences for Rs. 393 crore
Reliance Strategic Business Ventures Limited, a wholly owned subsidiary of Reliance Industries Limited has acquired stake in Strand Life Sciences... Read More
6
Sep
2021
DRL enters agreement to sell its rights to anti-cancer agent E7777 to Citius Pharma
Dr Reddy’s Laboratories Ltd announced that it has entered into a definitive agreement with Citius Pharmaceuticals, Inc. pursuant to which... Read More
31
Jul
2021
Takeda and Frazier announced a collaboration to launch HilleVax, Inc, a biopharmaceutical company, to develop and commercialize Takeda’s norovirus vaccine candidate
Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners announced a collaboration to launch HilleVax, Inc, a biopharmaceutical company, to develop... Read More
19
Jul
2021
Case Insight: Piramal Pharma’s acquisition of Hemmo Pharmaceuticals
Piramal Pharma Ltd has completed the acquisition of Hemmo Pharmaceuticals. In March this year, Piramal Pharma Ltd entered into an... Read More
19
Jul
2021
Rossari Biotech to acquire Tristar Intermediates
Rossari Biotech Ltd, a speciality chemicals manufacturer, on Sunday announced the acquisition of Tristar Intermediates at an enterprise value of... Read More
16
Jul
2021
Sun Pharma launches a special initiative ‘Sunkalp’ for the welfare of doctors
Sun Pharmaceutical Industries launched a special initiative ‘Sunkalp’ for the welfare of doctors, their families and the community. The company... Read More
16
Jul
2021
Kintor Pharmaceutical collaborates with Fosun Pharma Development to Commercialise Proxalutamide
Kintor Pharmaceutical Limited today announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical Development Ltd. (“Fosun... Read More
14
Jun
2021
Lupin’s Somerset plant received US FDA warning letter for
Lupin has received a warning letter from the US Food and Drug Administration relating to its US-based manufacturing plant located... Read More
12
Jun
2021
What is Cytokine Storm?
Cytokine Storm is a severe immune reaction in which the body releases too many cytokines into the blood too quickly.... Read More
10
Jun
2021
FDA Grants Accelerated Approval for Alzheimer’s drug Aduhelm
USFDA approved Aduhelm (aducanumab) for the treatment of Alzheimer disease. Alzheimer’s drug Aduhelm is research molecule of Neurimmune. Neurimmune licensed... Read More
10
Jun
2021
Insight on Neurogastrx licensing deal with Daewoong Pharmaceutical to Develop Fexuprazan
Neurogastrx, Inc. has entered into an exclusive license agreement with Daewoong Pharmaceutical Co., Ltd., of Seoul, South Korea, for the... Read More
4
Jun
2021
Case study – Adagrasib out licensing deal
Zai Lab said on Tuesday it has entered into a license agreement with Mirati Therapeutics to develop and commercialize Mirati’s KRAS... Read More
4
Jun
2021
CardioFocus Announces Agreement with China Grand Pharmaceutical to Bring HeartLight X3 System to China
CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has... Read More
4
Jun
2021
Cosentyx of Novartis Gets US FDA approval in Pediatric Plaque Psoriasis
The U.S. Food and Drug Administration (FDA) has approved Novartis’ blockbuster drug Cosentyx® (secukinumab) for pediatric patients aged six years and older with moderate-to-severe... Read More
3
Jun
2021
Corbus Pharma in-licenses two integrin targeting MAbs
US biotech Corbus Pharmaceuticals (Nasdaq: CRBP) today announced the expansion of its portfolio into immuno-oncology through licensing deals for two... Read More
3
Jun
2021
Case Study: Strategic Insight of acquisition of Constellation Pharmaceuticals by MorphoSys
MorphoSys AG, and Constellation Pharmaceuticals, Inc. announced that they have entered into a definitive agreement whereby MorphoSys will acquire Constellation... Read More
3
Jun
2021
Amryt’s filed Oleogel-S10 NDA for the treatment of Epidermolysis Bullosa
Amryt, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that... Read More
3
Jun
2021
Insight on Sun Pharma’s Licensing Agreement with Ferring Pharmaceutical for Caritec in India
Sun Pharmaceutical Industries entered into a licensing agreement with Ferring Pharmaceuticals to commercialise innovative obstetric drug Caritec in India. One... Read More
28
May
2021
EMA authorises Pfizer covid vaccine “Comirnaty” for 12-15 yrs
EMA has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 12... Read More
28
May
2021
Insight on US FDA approval of Myfembree OD treatment for management of heavy menstrual bleeding associated with uterine fibroids
Myovant Sciences and Pfizer announced that the US Food and Drug Administration (FDA) has approved Myfembree (relugolix 40 mg, estradiol... Read More
28
May
2021
Carlyle Group to acquire british pharma firm Vectura for $1.4bn
Private equity firm Carlyle Group on Wednesday announced plans to buy U.K. drug contractor Vectura in a deal that values... Read More
11
May
2021
DCGI – India approved anti-Covid drug 2-DG developed by DRDO for emergency use
The Drugs Controller General of India has approved an anti-COVID-19 drug developed by the Institute of Nuclear Medicine and Allied... Read More
11
May
2021
Eli Lilly to partner with Cipla, Lupin, Sun Pharma to manufacture, distribute Baricitinib in India
US drug-maker Eli Lilly, on May 10, announced that it had issued royalty-free, non-exclusive voluntary licenses to established Indian pharmaceutical... Read More